Back
Speaker illustration

Doctor Jacopo Francesco Imberti

Modena Polyclinic Modena University Hospital, Modena (Italy)

Member of:

European Society of Cardiology
European Heart Rythm Association

Jacopo F. Imberti is an Assistant Professor in Tenure Track at the University of Modena, Italy and Consultant Cardiologist at the A.O. Policlinico di Modena, Italy. His interest in cardiology and clinical research dates back to the Medical School he attended at University of Pavia. Driven by this passion, in 2016 he graduated with a research dissertation on catecholaminergic polymorphic ventricular tachycardia under the supervision of Prof. Silvia G. Priori. In 2018 he began the four years residency in cardiology at the A.O. Policlinico di Modena, where he is currently working with Prof. Giuseppe Boriani. Since 2020 he is also Clinical Research Fellow at the Liverpool Heart and Chest Hospital under the supervision of Prof. Gregory YH Lip. His main research fields are atrial fibrillation, arrhythmias, AHRE, stroke, and implantable cardiac devices.

Presentations Articles

The emerging role of AI/Ml for clinical decision-making in stroke and cardiac disease

Event: ESC Heart & Stroke 2024

Topic: Stroke

Session: 'Rise of the Machines’ – using AI/ML for stroke and cardiac management

Access
Like
Thumbnail

Long-term blood pressure targets after stroke: how low is too low?

Event: ESC Heart & Stroke 2024

Topic: Stroke

Session: Integrated Stroke Care and Stroke-Heart Syndrome

Access
Like
Thumbnail

New Atrial Fibrillation peri-ACS – which antithrombotic regimen and for how long?

Event: ESC Heart & Stroke 2024

Topic: Epidemiology, Prognosis, Outcome

Session: The heart-brain interaction: balancing thrombosis and bleeding risk in special populations (Joint Session with ESC Working Group on Thrombosis)

Access
Like
Thumbnail

Atrial cardiopathy: Insights from the new EHRA position paper and what‘s next after ARCADIA?

Event: ESC Heart & Stroke 2024

Topic: Stroke

Session: ESUS: what's new? Focus on Council on Stroke Position Paper

Access
Like
Thumbnail

Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial aibrillation: a report from 2 prospective observational registries

Event: ESC Congress 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Management of comorbidities and outcomes in atrial fibrillation (1)

Access
Like
Thumbnail

Is there a need for CIED reusage in Europe and elsewhere?

Event: EHRA 2024

Topic: Public Health and Health Economics, Other

Session: Sustainability and arrhythmia treatment: what are the arguments?

Access
Like
Thumbnail

Atrial high-rate episodes detected by cardiac implantable electronic devices: arrhythmic burden and progression towards de-novo clinical atrial fibrillation

Event: EHRA 2024

Topic: Defining Types of Atrial Fibrillation

Session: Atrial fibrillation: diagnostic - clinical

Access
Like
Thumbnail

Right and left atrial echocardiographic parameters and outcome in patients with atrial fibrillation

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Risk factors and outcome in patients with atrial fibrillation

Access
Like
Thumbnail

Low incidence rate of infections associated with cardiac implantable electronic device procedures in a large real-world patient cohort

Event: EHRA 2023

Topic: Device Complications and Lead Extraction

Session: ePoster session 9

Access
Like
Thumbnail

Anaemia and adverse outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry

Event: ESC Congress 2022

Topic: Clinical

Session: Clinical arrhythmia issues in everyday practice

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources